Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Strategies for the biological evaluation of gold anticancer agentsSimon P FrickerMetallomics : Integrated Biometal Science|November 13, 2010
Cysteine proteases as targets for metal-based drugsSimon P FrickerTransfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 2, 2013
Physiology and pharmacology of plerixaforSimon P FrickerExpert Opinion on Investigational Drugs|October 17, 2008
A novel CXCR4 antagonist for hematopoietic stem cell mobilizationSimon P FrickerFuture Medicinal Chemistry|December 24, 2013
Chemokine receptor modeling: an interdisciplinary approach to drug designSimon P Fricker, Markus MetzClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
CXCL12 (SDF-1)/CXCR4 pathway in cancerBeverly A Teicher, Simon P FrickerMethods in Molecular Biology (Clifton, N.J.)|June 11, 2009
A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discoveryJean Labrecque, Rebecca S Y Wong, Simon P FrickerCurrent Topics in Medicinal Chemistry|December 8, 2004
Ruthenium as an effective nitric oxide scavengerCeline J Marmion, Beth Cameron, Clodagh Mulcahy, et al.The Journal of Biological Chemistry|March 14, 2015
Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198Gloria Lau, Jean Labrecque, Markus Metz, et al.Pageof 3